Saturday, October 5, 2024
In the arid and semi-arid landscapes of District Vehari, Punjab, Pakistan, groundwater remains the lifeline for many communities, particularly in healthcare settings. However, contamination of this precious resource poses...
Key TakeawaysVirica Biotech and Ginkgo Bioworks have joined forces to enhance adeno-associated virus gene therapy production by combining Ginkgo’s advanced screening platform with Virica’s Viral Sensitizers, aiming to...
Key TakeawaysIn the Phase 3b/4 PSORIATYK SCALP trial, Sotyktu demonstrated a significant improvement in moderate-to-severe scalp psoriasis, with 48.5% of patients achieving clear or almost clear skin compared...
Key TakeawaysEli Lilly announced the creation of a groundbreaking $4.5 billion "Lilly Medicine Foundry" in Indiana, aiming to revolutionize drug production and accelerate clinical trials for next-generation medicines. ...

Upcoming Meetings

spot_img
  • HTAi 2024 Asia Policy Forum

    Mark your calendars for a groundbreaking event in the world of Health Technology Assessment (HTA) as...

    November 6 - November 8
  • Access Forum : Addressing Challenges Impacting Patient Access

    Join us for the 2nd annual ACCESS EU conference in Barcelona, Spain, themed “Addressing Challenges...

    November 14 - November 16
  • ISPOR Europe 2024

    Now is the opportunity to connect with worldwide healthcare leaders who share your passion for Healt...

    November 17 - November 20
  • 7th Health Economics Congress

    The Health Economics and Policy Association (SaÄŸlık Ekonomisi ve Politikası DerneÄŸi – SEPD...

    December 12-08:00 - December 13-17:00
  • World EPA Congress 2025

    The World Evidence, Pricing and Access (EPA) Congress is set to take center stage as Europe’s ...

    March 5, 2025 - March 6, 2025

Editor's Picks

Pharmacoeconomics

Latest News
Latest

Urgent Need for Safe Groundwater Management in Punjab’s Healthcare Facilities

In the arid and semi-arid landscapes of District Vehari, Punjab, Pakistan, groundwater remains the lifeline for many communities, particularly in healthcare settings. However, contamination...

Innovative Approach to Evaluating Healthcare Quality Amidst Challenges

In a rapidly evolving healthcare landscape, ensuring quality service delivery remains a formidable challenge. This is exacerbated by the complex and multifaceted nature of...

Effectiveness of Speech Therapies for Parkinson’s: A Comparative Study

The PD COMM trial delves into the challenges faced by individuals with Parkinson's disease, focusing on speech impairments that lead to increased conversational demands...

ABPI Welcomes UN General Assembly’s Renewed Commitment to Combat Antimicrobial Resistance

Key TakeawaysGlobal collaboration on antimicrobial resistance (AMR) was emphasized at the United Nations General Assembly during its 79th session. The UK's leadership in...

ABPI Preparing for the Windsor Framework: Ensuring Smooth UK Medicines Supply Beyond 2025

Key TakeawaysThe Windsor Framework, fully effective from January 2025, introduces a two-category system for UK medicines, increasing regulatory complexity between the UK and...

Adeno-Associated Virus Manufacturing Enhanced by Virica and Ginkgo Partnership to Lower Gene Therapy Costs

Key TakeawaysVirica Biotech and Ginkgo Bioworks have joined forces to enhance adeno-associated virus gene therapy production by combining Ginkgo’s advanced screening platform with...

NHS-Industry Partnerships Improve Patient Outcomes and Prescribing Practices, Report Shows

Key TakeawaysEarly research suggests that NHS-industry partnerships significantly improve patient care, with hospitals up to 2.5 times more likely to follow NICE guidelines. ...

Lower Back Pain Treatment Advances with New ICD-10 Code for Multifidus Muscle Dysfunction and ReActiv8 Therapy

Key TakeawaysThe U.S. CDC has introduced a new ICD-10-CM diagnostic code, M62.85, specifically for multifidus muscle dysfunction in the lumbar region, recognizing its...

JUVÉDERM® VOLUMA® XC Now Nationwide for Treating Moderate to Severe Temple Hollowing

Key TakeawaysJUVÉDERM® VOLUMA® XC, the first and only FDA-approved hyaluronic acid filler for temple hollowing, is now available across the U.S. Over 85%...

Dry Eye Disease Treatment Advances with EU Approval of Vevizye® for Moderate to Severe Cases

Key TakeawaysNovaliq and Laboratoires Théa announced that Vevizye® has been approved by the European Commission for the treatment of moderate to severe dry...

HEOR

MedTech